Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 24Hereditary Sensory and Autonomic Neuropathies 6Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Recurrence 2Ovarian Neoplasms 2Multiple Endocrine Neoplasia Type 1 2Head and Neck Neoplasms 2Advanced Breast Cancer 2Triple Negative Breast Neoplasms 1Stomach Neoplasms Esophageal Neoplasms Metastatic Gastric Cancer Mutated PI3KCA Protein Overexpressed HER2 Protein 1Pre-menopausal Breast Cancer 1Neoplasm Metastasis 1Multiple Myeloma 1Lymphatic Abnormalities 1Lymphangioma, Cystic 1Lymphangioma 1Kidney Neoplasms 1Hyperglycemia 1HER2-positive Metastatic Breast Cancer 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Endometrial Neoplasms 1Colorectal Neoplasms 1Carcinoma, Renal Cell 1Advanced or Metastatic ER+ Breast Cancer 1Advanced and Selected Solid Tumors 1Advanced Solid Tumors With an Alteration of the PIK3CA Gene 1Advanced Solid Tumor 1Advanced HER2+Breast Cancer 1

Interventions

pemigatinib 6infigratinib 2erdafitinib 2derazantinib 2pembrolizumab 1exemestane 1atezolizumab 1Rogaratinib 1INCB 54828-101 1Gemcitabine 1Fulvestrant 1Drug Combinations 1Carboplatin 1Alpelisib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Acrocephalosyndactylia × Alpelisib × Clear all
NCT01928459 2020-12-09

Phase 1b Trial of BGJ398/BYL719 in Solid Tumors

Novartis

Phase 1 Completed
62 enrolled
Breast

Acrocephalosyndactylia, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡